Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study
β Scribed by Wolfgang Eiermann; Wolf Achterrath; Luigi Lenaz; Hermann Hepp
- Book ID
- 104888104
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 494 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: For advanced colorectal carcinoma, 5-fluorouracil (5-fu)-leucovorin is the best therapy available. to improve results, a variety of drugs were added, including cisplatin (cddp), sometimes with controversial results. the combination of cddp and etoposide (vp-16) has shown synergistic
Background. In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease. Thirty-six evaluable patients were treated with two or three courses of methotrexate, vincristine, prednisone, leucovorin, etoposide, and cyclophos